Q4 2024 Earnings Conference Call January 31, 2025 9:00 AM ETCompany ParticipantsKate Winslow - IRChad Abraham - ...

Piper Sandler adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) shares, reducing it from the previous $1,195.00 to $1,013.00. Despite this change, the firm maintained its ...

Travelers Companies Inc. (NYSE:TRV), a $54.7 billion insurance giant trading at 11.5x earnings, received an upgrade in its ...

The technology vendor is going outside the company to hire PNC vet Michael Lyons to replace Trump administration-bound Frank Bisignano, leaving the Pittsburgh-bank without its heir apparent for the ...

Analysts at Piper Sandler also addressed concerns about the company’s second-half guidance for 2025 ... outperform Q4 expectations and set comfortable 2025 guidance. RBC Capital Markets also provided ...

Analysts at Piper Sandler also addressed concerns about the company's second-half guidance ... and set comfortable 2025 guidance. RBC Capital Markets also provided a favorable outlook for the ...

Analysts from Piper Sandler, RBC Capital Markets, and BofA Securities expressed optimism for DexCom, with Piper Sandler expecting the company to maintain its 15% revenue growth outlook for 2025 and ...